Critical analysis of a multicentric experience with holmium laser enucleation of the prostate for benign prostatic hyperplasia: outcomes and complications of 10 years of routine clinical practice.

Javier Romero Otero Borja García GómezLucía García-GonzálezEsther García-RojoPablo Abad-LópezJuan Justo-QuintasJosé Duarte-OjedaAlfredo Rodríguez-Antolín

Published in: BJU international (2020)

HoLEP is suitable for real-life patients with BPH, irrespective of the presence of active treatment with anticoagulant/antiplatelet, bladder lithiasis or a prostate ≥100 mL.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
clinical practice
spinal cord injury
atrial fibrillation
venous thromboembolism
prostate cancer
risk factors
metabolic syndrome
adipose tissue
mass spectrometry
skeletal muscle
insulin resistance
high speed
replacement therapy
glycemic control
urinary tract